Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori S.r.l.

Meldola 8 trials 2 recruiting

8 Registered trials

2 Currently recruiting

Organisation

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori S.r.l.

Location

Meldola, Italy

Identifier

ORG-100010212

Address

Via Piero Maroncelli 40, 47014, Italy

Departments

Divisione di Oncologia Medica
Ematologia
Medical oncology
Medical Oncology Department
Oncologia Medica
SSD di Immunoterapia

Clinical trials at this site (8)

Search interface

Clinical trial of MK-7648A in adults and children with skin cancer Not authorised

2022-501417-31-00 High-risk Resected Melanoma 5
A Study of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with R/R PTCL Recruiting

2022-500391-62-00 Subjects with relapsed/refractory peripheral T-cell lym 9 2023-01-19
A Study of Abemaciclib (LY2835219) with Abiraterone in Men with Prostate Cancer that has Spread to Other Parts of the Body and is Expected t… Recruiting

2022-500461-28-06 High-Risk Metastatic Hormone-Sensitive Prostate Cancer 5 2022-09-15
Phase 3 Study to Evaluate Mezigdomide (CC-92480/BMS-986348) in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Mult… Ended

2022-500861-29-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2023-01-12
Clinical trial of MK-7648A in adults and children with skin cancer Ended

2022-501417-31-01 melanoma 5 2023-08-01
A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus … Ended

2022-500177-13-00 Metastatic Colorectal Cancer (mCRC) 4 2023-06-02
Clinical study to investigate the efficacy of botensilimab (AGEN1181) in patients with advanced melanoma refractory to prior checkpoint inhi… Ended

2022-500652-37-00 Advanced melanoma refractory to prior checkpoint inhibi 4 2022-12-01
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3… Ended

2022-501251-81-00 Renal cell carcinoma 5 2017-06-08